TXMD
TherapeuticsMD Inc.
$2.11
-$0.01(-0.47%)
44
Overall
60
Value
30
Tech
42
Quality
Market Cap
$15.86M
Volume
20.44K
52W Range
$0.98 - $2.95
Target Price
$5.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $19.4M | $16.8M | $16.1M | $49.6M | $64.9M | $2.6M | $70.0M | $1.3M | $3.1M | $4.9M | ||
| Total Revenue | $19.4M | $16.8M | $16.1M | $49.6M | $64.9M | $2.6M | $70.0M | $1.3M | $1.8M | $3.0M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-4.2M | $-2.6M | $-2.7M | $6.3M | $16.0M | $1.4M | $1.4M | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $15.2M | $14.1M | $13.4M | $43.3M | $48.9M | $1.2M | $68.6M | $1.3M | $1.8M | $3.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-105.4M | $-91.8M | $-143.6M | $194.5M | $204.4M | $80.7M | $57.9M | $9.8M | $7.9M | $7.4M | ||
| Research & Development | $53.9M | $33.9M | $27.3M | $19.8M | $10.4M | $7.1M | -- | -- | -- | -- | ||
| Research Expense | $53.9M | $33.9M | $27.3M | $19.8M | $10.4M | $7.1M | -- | -- | -- | -- | ||
| Selling, General & Administrative | $51.3M | $57.7M | $116.0M | $174.1M | $194.0M | $80.7M | $56.7M | $8.9M | $6.1M | $7.2M | ||
| Selling & Marketing Expenses | $51.3M | $57.7M | $116.0M | $9.0M | $117.1M | $39.7M | $13.2M | -- | -- | $384.0K | ||
| General & Administrative Expenses | $-709.8K | $-1.0M | $-1.1M | $174.1M | $77.0M | $80.7M | $56.7M | $8.9M | $6.1M | $6.9M | ||
| Promotion & Advertising | $-752.6K | $-448.3K | $-1.7M | $9.0M | $35.8M | $39.7M | $13.2M | -- | -- | -- | ||
| Salaries & Wages | $-17.4M | $-6.9M | $-8.7M | $10.7M | $10.7M | $-278.0K | $11.6M | $1.3M | -- | -- | ||
| Depreciation & Amortization | $132.5K | $213.1K | $293.9K | $612.8K | $800.0K | $400.0K | $1.2M | $922.0K | $1.3M | $176.0K | ||
| Depreciation & Amortization | $132.5K | $213.1K | $293.9K | $612.8K | $1.0M | $400.0K | $1.2M | $922.0K | $1.3M | $176.0K | ||
| Amortization | $-54.5K | $-71.5K | $-382.3K | $6.1M | $41.4M | $7.1M | $6.9M | $6.1M | $1.3M | $176.0K | ||
| Other Operating Expenses | -- | -- | -- | $1.6M | $2.3M | $2.1M | $2.1M | $2.3M | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-90.3M | $-77.6M | $-130.2M | $-151.2M | $-155.5M | $-79.6M | $10.7M | $-8.5M | $-6.1M | $-4.4M | ||
| EBITDA | $-89.7M | $-76.7M | $-127.4M | $-156.5M | $-153.4M | $-78.8M | $11.9M | $-6.7M | $-1.1M | $540.0K | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | $4.7M | $17.4M | $26.0M | $22.6M | $13.5M | $166.6K | -- | -- | ||
| Intinc | $10.8K | -- | -- | -- | -- | -- | -- | $297.9K | $135.0K | $142.0K | ||
| Net Non-Operating Interest Income/Expense | $10.8K | -- | $-4.7M | $-17.4M | $-28.6M | $-32.9M | $-13.5M | $131.3K | $135.0K | $142.0K | ||
| Other Income/Expense | $-378.1K | $-703.3K | $-2.3M | $7.6M | $-598.0K | $-272.0K | $-9.6M | $-1.4M | $509.0K | -- | ||
| Other Special Charges | $378.1K | $703.3K | $2.3M | $-7.6M | $598.0K | $272.0K | $-117.0K | $1.4M | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | $9.5M | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | $-9.5M | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $78.9K | $1.1M | -- | -- | -- | $1.3M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-89.9M | $-76.9M | $-127.9M | $-158.8M | $-157.5M | $-79.6M | $10.7M | $-7.6M | $-2.3M | $-653.0K | ||
| Pre-Tax Income | $-89.9M | $-76.9M | $-132.6M | $-176.1M | $-183.5M | $-79.3M | $1.1M | $-7.7M | $-2.3M | $-653.0K | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | -- | -- | -- | -- | -- | $-43.0K | $-31.0K | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-89.9M | $-76.9M | $-132.6M | $-176.1M | $-183.5M | $-172.4M | $112.0M | $-10.3M | $-2.2M | $-569.0K | ||
| Net Income (Continuing Operations) | $-89.9M | $-76.9M | $-132.6M | $-176.1M | $-183.5M | $-172.4M | $1.1M | $-7.7M | $-2.3M | $-653.0K | ||
| Net Income (Discontinued Operations) | $-89.9M | $-76.9M | $-132.6M | $-176.1M | $-183.5M | $-172.4M | $112.0M | $-10.3M | $-2.2M | $-569.0K | ||
| Net Income (Common Stockholders) | $-89.9M | $-76.9M | $-132.6M | $-176.1M | $-183.5M | $-79.3M | $112.0M | $-10.3M | $-2.2M | $-569.0K | ||
| Normalized Income | -- | -- | -- | -- | -- | $-62.7M | -- | -- | -- | $-646.5K | ||
| TOTALS | ||||||||||||
| Total Expenses | $-109.6M | $-94.4M | $-146.3M | $200.9M | $220.4M | $82.2M | $59.3M | $9.8M | $7.9M | $7.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $3.9M | $4.1M | $4.5M | $4.9M | $5.5M | $8.0M | $9.0M | $10.4M | $11.5K | $11.6M | ||
| Average Shares Outstanding (Diluted) | $3.9M | $4.2M | $4.5M | $4.9M | -- | $8.0M | $9.4M | $10.4M | $11.5K | $11.6M | ||
| Shares Outstanding | $4.0M | $4.3M | $4.8M | $5.4M | $7.8M | $8.7M | $10.0M | $11.6M | $11.6M | $11.6M | ||
| Basic EPS | -- | -- | -- | $-36 | $-33.5 | $-21.5 | $12.41 | $-0.98 | $-0.19 | $-0.05 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-36 | $-33.5 | $-21.5 | $0.12 | $-0.74 | $-0.20 | $-0.06 | ||
| Diluted EPS | $-23 | $-18.5 | $-29.5 | $-36 | $-33.5 | $-21.5 | $11.95 | $-0.98 | $-0.19 | $-0.05 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $0.11 | $-0.74 | $-0.20 | $-0.06 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | -- | -- | $509.0K | -- | ||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | $12.29 | $-0.25 | $0.01 | $0.01 | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | $11.84 | $-0.25 | $0.01 | $0.01 | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | -- | $-93.1M | $110.9M | $-2.6M | $131.0K | $84.0K | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | -- | $-93.1M | $110.9M | $-2.6M | $131.0K | $84.0K | ||
| Other Gand A | $-709.8K | $-1.0M | $-1.1M | $174.1M | $77.0M | $80.7M | $56.7M | $8.9M | $6.1M | $6.9M | ||
| Other Write Down | -- | -- | -- | -- | $275.4K | -- | -- | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | $24.0K | $317.0K | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-709.8K | $-1.0M | $-1.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $51.3M | $57.7M | $116.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | $9.5M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TXMD | $2.11 | -0.5% | 20.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |